Posted on
April 4, 2023

2nd Annual a2 National Symposium @ UPENN

a2 National Symposium registration link:

As technology continues to evolve and shape the future of healthcare, the a2 Collective invites innovators, academics, and industry leaders to convene at the University of Pennsylvania's Smilow Center for Translational Research on March 19-20, 2024. Backed by the National Institute on Aging and other key sponsors (tba), this 2-day event is bound to spark dialogue, foster collaboration, and ignite the next wave of transformative ideas in AgeTech, AI, healthy aging, and Alzheimer’s disease and related dementias (AD/ADRD).


This symposium isn't your standard tech event. With a special focus on AI and AgeTech, we're addressing challenges and celebrating innovations to improve care and health outcomes for our aging population. Engage with awardees from both the first and second cohorts, executives from the healthcare industry, capital allocators, renowned academic experts, clinical researchers, and a host of tech startups ready to shape the future of healthtech. If you're an investor, this is your prime opportunity to meet game-changing startups in the AI, AgeTech, and AD/ADRD space.


Dr. Suchi Saria: As co-director of the Aging Pilot Core at JH AITC and the founder and CEO of Bayesian Health, whose AI-driven platform for physicians was selected by TIME as a best invention of 2023, Dr. Saria is no stranger to the intersection of AI and healthcare. Her dedication to personalizing healthcare decisions through AI is both impressive and inspiring. Her awards, including the World Economic Forum’s Young Global Leader and MIT Technology Review’s 35 Innovators Under 35, are a testament to her groundbreaking work in the field.

Dr. Joel Dudley: Holding a partnership at Innovation Endeavors and having co-founded companies focused on leveraging AI in healthcare, Dr. Dudley offers a wealth of knowledge and experience. With a doctorate in biomedical informatics from Stanford University, his contributions to AI in healthcare are both prolific and impactful.

Andrew Toy: As the CEO of Clover Health, Toy is at the helm of a technology-first Medicare company aiming to revolutionize senior healthcare. With a past tenure at Google leading development for the Google Cloud and Android for Work, his insights on the role of machine learning in healthcare are indispensable.


Awardee Pitch Competition: Take in innovative project pitches from a2 Pilot Awardees who are aiming to redefine healthtech for the aging population.

Awardee Poster Presentations: Delve further into a2 Pilot Awardees’ projects with an opportunity for one-on-one engagement and deeper understanding.

Panel Discussions: Engage in enriching discussions on AgeTech funding and entrepreneurship, generative AI and aging, and stakeholders’ lived experience.


The future of AI and AgeTech is not just in the hands of developers and researchers; it’s in collaborative efforts, shared knowledge, and collective ambition. Join us in Philadelphia and be part of this transformative journey.

Register now and secure your place at the epicenter of AgeTech and AI innovation. For attendees from out of town, make sure to take advantage of the special rates at The Study Hotel, a venue that mirrors the symposium’s ethos of innovation and academia. The most up to date conference and hotel details can be found at A direct link to the Eventbrite registration link is here:

The Research Centers Collaborative Network (RCCN) is also offering travel awards to the a2 National Symposium. For details on how to apply, click here.

Hosted by PennAITech, MassAITC, JH AITC, and the a2 Collective Coordinating Center. We'd also like to thank the National Institute on Aging for primary funding and support.